Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase

Inorganic anions inhibit the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1) generally by coordinating to the active site metal ion. Cyanate was reported as a non-coordinating CA inhibitor but those erroneous results were subsequently corrected by another group. We review the anion CA inhibitors (...

Full description

Bibliographic Details
Main Authors: Alessio Nocentini, Andrea Angeli, Fabrizio Carta, Jean-Yves Winum, Raivis Zalubovskis, Simone Carradori, Clemente Capasso, William A. Donald, Claudiu T. Supuran
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:http://dx.doi.org/10.1080/14756366.2021.1882453
_version_ 1818954320698146816
author Alessio Nocentini
Andrea Angeli
Fabrizio Carta
Jean-Yves Winum
Raivis Zalubovskis
Simone Carradori
Clemente Capasso
William A. Donald
Claudiu T. Supuran
author_facet Alessio Nocentini
Andrea Angeli
Fabrizio Carta
Jean-Yves Winum
Raivis Zalubovskis
Simone Carradori
Clemente Capasso
William A. Donald
Claudiu T. Supuran
author_sort Alessio Nocentini
collection DOAJ
description Inorganic anions inhibit the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1) generally by coordinating to the active site metal ion. Cyanate was reported as a non-coordinating CA inhibitor but those erroneous results were subsequently corrected by another group. We review the anion CA inhibitors (CAIs) in the more general context of drug design studies and the discovery of a large number of inhibitor classes and inhibition mechanisms, including zinc binders (sulphonamides and isosteres, dithiocabamates and isosteres, thiols, selenols, benzoxaboroles, ninhydrins, etc.); inhibitors anchoring to the zinc-coordinated water molecule (phenols, polyamines, sulfocoumarins, thioxocoumarins, catechols); CAIs occluding the entrance to the active site (coumarins and derivatives, lacosamide), as well as compounds that bind outside the active site. All these new chemotypes integrated with a general procedure for obtaining isoform-selective compounds (the tail approach) has resulted, through the guidance of rigorous X-ray crystallography experiments, in the development of highly selective CAIs for all human CA isoforms with many pharmacological applications.
first_indexed 2024-12-20T10:20:18Z
format Article
id doaj.art-c312ff071beb4ce3a541ee3fd2098cc5
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2024-12-20T10:20:18Z
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-c312ff071beb4ce3a541ee3fd2098cc52022-12-21T19:43:56ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742021-01-0136156158010.1080/14756366.2021.18824531882453Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydraseAlessio Nocentini0Andrea Angeli1Fabrizio Carta2Jean-Yves Winum3Raivis Zalubovskis4Simone Carradori5Clemente Capasso6William A. Donald7Claudiu T. Supuran8Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of FlorenceNeurofarba Department, Pharmaceutical and Nutraceutical Section, University of FlorenceNeurofarba Department, Pharmaceutical and Nutraceutical Section, University of FlorenceIBMM, Univ. Montpellier, CNRS, ENSCMLatvian Institute of Organic SynthesisDepartment of Pharmacy, "G. d'Annunzio" University of Chieti-PescaraInstitute of Biosciences and Bioresources, National Research CouncilSchool of Chemistry, University of New South WalesNeurofarba Department, Pharmaceutical and Nutraceutical Section, University of FlorenceInorganic anions inhibit the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1) generally by coordinating to the active site metal ion. Cyanate was reported as a non-coordinating CA inhibitor but those erroneous results were subsequently corrected by another group. We review the anion CA inhibitors (CAIs) in the more general context of drug design studies and the discovery of a large number of inhibitor classes and inhibition mechanisms, including zinc binders (sulphonamides and isosteres, dithiocabamates and isosteres, thiols, selenols, benzoxaboroles, ninhydrins, etc.); inhibitors anchoring to the zinc-coordinated water molecule (phenols, polyamines, sulfocoumarins, thioxocoumarins, catechols); CAIs occluding the entrance to the active site (coumarins and derivatives, lacosamide), as well as compounds that bind outside the active site. All these new chemotypes integrated with a general procedure for obtaining isoform-selective compounds (the tail approach) has resulted, through the guidance of rigorous X-ray crystallography experiments, in the development of highly selective CAIs for all human CA isoforms with many pharmacological applications.http://dx.doi.org/10.1080/14756366.2021.1882453carbonic anhydraseinhibitorsulphonamideinhibition mechanismscyanate
spellingShingle Alessio Nocentini
Andrea Angeli
Fabrizio Carta
Jean-Yves Winum
Raivis Zalubovskis
Simone Carradori
Clemente Capasso
William A. Donald
Claudiu T. Supuran
Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase
Journal of Enzyme Inhibition and Medicinal Chemistry
carbonic anhydrase
inhibitor
sulphonamide
inhibition mechanisms
cyanate
title Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase
title_full Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase
title_fullStr Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase
title_full_unstemmed Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase
title_short Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase
title_sort reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase
topic carbonic anhydrase
inhibitor
sulphonamide
inhibition mechanisms
cyanate
url http://dx.doi.org/10.1080/14756366.2021.1882453
work_keys_str_mv AT alessionocentini reconsideringanioninhibitorsinthegeneralcontextofdrugdesignstudiesofmodulatorsofactivityoftheclassicalenzymecarbonicanhydrase
AT andreaangeli reconsideringanioninhibitorsinthegeneralcontextofdrugdesignstudiesofmodulatorsofactivityoftheclassicalenzymecarbonicanhydrase
AT fabriziocarta reconsideringanioninhibitorsinthegeneralcontextofdrugdesignstudiesofmodulatorsofactivityoftheclassicalenzymecarbonicanhydrase
AT jeanyveswinum reconsideringanioninhibitorsinthegeneralcontextofdrugdesignstudiesofmodulatorsofactivityoftheclassicalenzymecarbonicanhydrase
AT raiviszalubovskis reconsideringanioninhibitorsinthegeneralcontextofdrugdesignstudiesofmodulatorsofactivityoftheclassicalenzymecarbonicanhydrase
AT simonecarradori reconsideringanioninhibitorsinthegeneralcontextofdrugdesignstudiesofmodulatorsofactivityoftheclassicalenzymecarbonicanhydrase
AT clementecapasso reconsideringanioninhibitorsinthegeneralcontextofdrugdesignstudiesofmodulatorsofactivityoftheclassicalenzymecarbonicanhydrase
AT williamadonald reconsideringanioninhibitorsinthegeneralcontextofdrugdesignstudiesofmodulatorsofactivityoftheclassicalenzymecarbonicanhydrase
AT claudiutsupuran reconsideringanioninhibitorsinthegeneralcontextofdrugdesignstudiesofmodulatorsofactivityoftheclassicalenzymecarbonicanhydrase